Patents Assigned to NeuMedics
  • Patent number: 10350257
    Abstract: The present invention provides a pharmaceutical or health functional food containing, as an active ingredient, a complex extract of Crataegi Fructus and Citri Pericarpium. The complex extract has the effects of reducing body weight and lipids in blood vessels.
    Type: Grant
    Filed: June 21, 2013
    Date of Patent: July 16, 2019
    Assignee: NEUMED
    Inventors: Juyeon Park, Dong Wook Lim, Mikyung Song
  • Publication number: 20150202244
    Abstract: The present invention provides a pharmaceutical or health functional food containing, as an active ingredient, a complex extract of aurantii nobilis pericarpium and crataegus. The complex extract has the effects of reducing body weight and lipids in blood vessels.
    Type: Application
    Filed: June 21, 2013
    Publication date: July 23, 2015
    Applicant: NEUMED
    Inventors: Juyeon Park, Dong Wook Lim, Mikyung Song
  • Patent number: 8338477
    Abstract: The present disclosure is directed to compositions and methods which utilize the tetracycline scaffold, preferably the scaffold of tetracycline or minocycline, and which significantly lack antibiotic activity. The compounds have neuroprotective attributes without interfering with the drugs capacity to pass through the blood brain barrier. These compounds have neuroprotective activity because of their inhibition of neuronal cell cycle progression. The compounds are characterized in part by a fifth ring joining positions 9 and 10.
    Type: Grant
    Filed: July 10, 2009
    Date of Patent: December 25, 2012
    Assignee: NeuMedics
    Inventors: Iain W. Duncan, Edward A. Kesicki, Carl G. Osborne, William D. Schwieterman, Irina Jacobson
  • Publication number: 20100009981
    Abstract: The present disclosure is directed to compositions and methods which utilize the tetracycline scaffold, preferably the scaffold of tetracycline or minocycline, and which significantly lack antibiotic activity. The compounds have neuroprotective attributes without interfering with the drugs capacity to pass through the blood brain barrier. These compounds have neuroprotective activity because of their inhibition of neuronal cell cycle progression. The compounds are characterized in part by a fifth ring joining positions 9 and 10.
    Type: Application
    Filed: July 10, 2009
    Publication date: January 14, 2010
    Applicant: Neumedics
    Inventors: Iain W. Duncan, Edward A. Kesicki, Carl G. Osborne, William D. Schwieterman, Irina Jacobson